Drug Shortage Report for DIASTAT
| Report ID | 177261 |
| Drug Identification Number | 02519089 |
| Brand name | DIASTAT |
| Common or Proper name | DIASTAT |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DIAZEPAM |
| Strength(s) | 15MG |
| Dosage form(s) | GEL |
| Route of administration | RECTAL |
| Packaging size | 2pk |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-02-10 |
| Actual start date | 2023-02-14 |
| Estimated end date | 2024-01-19 |
| Actual end date | 2024-01-17 |
| Shortage status | Resolved |
| Updated date | 2024-01-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-12-07 | English | Compare |
| v2 | 2022-12-07 | French | Compare |
| v3 | 2023-02-08 | English | Compare |
| v4 | 2023-02-08 | French | Compare |
| v5 | 2023-02-11 | English | Compare |
| v6 | 2023-03-23 | English | Compare |
| v7 | 2023-03-23 | French | Compare |
| v8 | 2023-04-11 | English | Compare |
| v9 | 2023-04-11 | French | Compare |
| v10 | 2023-05-25 | English | Compare |
| v11 | 2023-05-25 | French | Compare |
| v12 | 2023-07-21 | English | Compare |
| v13 | 2023-07-21 | French | Compare |
| v14 | 2023-08-09 | English | Compare |
| v15 | 2023-08-09 | French | Compare |
| v16 | 2023-08-23 | English | Compare |
| v17 | 2023-08-23 | French | Compare |
| v18 | 2023-09-15 | English | Compare |
| v19 | 2023-09-15 | French | Compare |
| v20 | 2023-10-19 | English | Compare |